Tern Plc comments on significant rise in the share price of Wyld Networks AB

Tern - Wyld Networks

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has noted the recent rise in the Company’s share price. The Board also notes today’s significant rise in the share price of Wyld Networks AB. Wyld Networks has published a press release today in relation to the signing of an agreement with SpaceX to discuss potential areas of collaboration.

Wyld Networks is a portfolio company of Tern’s in which Tern currently owns approximately 27%.

Extracted from a translation of the Wyld Networks press release:

“Space X offers satellite connectivity for broadband through Starlink and connectivity for IoT through Swarm. Wyld and SpaceX will explore potential areas of collaboration to collect data from IoT sensors in remote locations.

Satellite connectivity can help bridge the digital divide and increase the reach and resilience of connections for IoT devices. This is particularly the case for the 85% of the Earth’s surface that has no cellular coverage.

Both SpaceX and Wyld Networks operate on low-bandwidth satellite connectivity using satellites orbiting in low orbit. These satellites cover every point on Earth, enabling IoT devices to operate and deliver data at an affordable price, anywhere on Earth.

SpaceX and Wyld will initially explore the potential of offering remote connectivity in North, Central and South America.

Wyld Networks’ IoT engineering team is a leader in delivering satellite IoT connectivity solutions. Their innovative technology leads to exceptional performance with satellites orbiting the Earth in low Earth orbit.

“We are excited to explore possible areas with SpaceX where our technology can enable additional connectivity and access to data from sensors and devices in remote locations,” said Alastair Williamson, CEO Wyld Networks. “With Wyld Connect available to deliver data from IoT devices anywhere on Earth, this is a great opportunity to partner with the world’s most important satellite companies.””

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Tern plc raises £450,000 in share placing ahead of AIM admission

Tern plc has raised £450,000 through a placing and outlined expected admission timing and updated voting rights.

AI search makes message measurement a healthcare priority

As AI changes search, healthcare companies need to know whether their messages are being seen, understood and represented correctly.

Search